Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Giuseppe Benagiano, Carlo Bastianelli, Manuela Farris & Ivo Brosens. (2014) Selective progesterone receptor modulators: an update. Expert Opinion on Pharmacotherapy 15:10, pages 1403-1415.
Read now
Read now
Giuseppe Benagiano, Carlo Bastianelli & Manuela Farris. (2008) Selective progesterone receptor modulators 3: use in oncology, endocrinology and psychiatry. Expert Opinion on Pharmacotherapy 9:14, pages 2487-2496.
Read now
Read now
Giuseppe Benagiano, Carlo Bastianelli & Manuela Farris. (2008) Selective progesterone receptor modulators 2: use in reproductive medicine. Expert Opinion on Pharmacotherapy 9:14, pages 2473-2485.
Read now
Read now
Articles from other publishers (15)
Jenny Katharina Wagner, Katarina Dathe, Christof Schaefer & Maria Hoeltzenbein. (2020) Ulipristal acetate and pregnancy outcome—an observational study. Human Reproduction 35:4, pages 751-758.
Crossref
Crossref
Hareesh B. Nair, Bindu Santhamma, Kalarickal V. Dileep, Peter Binkley, Kirk Acosta, Kam Y. J. Zhang, Robert Schenken & Klaus Nickisch. (2019) EC313-a tissue selective SPRM reduces the growth and proliferation of uterine fibroids in a human uterine fibroid tissue xenograft model. Scientific Reports 9:1.
Crossref
Crossref
C. Denise Okafor, Jennifer K. Colucci & Eric A. Ortlund. (2019) Ligand-Induced Allosteric Effects Governing SR Signaling. Nuclear Receptor Research 6.
Crossref
Crossref
Martin Puhr, Julia Hoefer, Andrea Eigentler, Christian Ploner, Florian Handle, Georg Schaefer, Jan Kroon, Angela Leo, Isabel Heidegger, Iris Eder, Zoran Culig, Gabri Van der Pluijm & Helmut Klocker. (2018) The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy. Clinical Cancer Research 24:4, pages 927-938.
Crossref
Crossref
Carlos D Gamarra-Luques, Maria B Hapon, Alicia A Goyeneche & Carlos M Telleria. (2014) Resistance to cisplatin and paclitaxel does not affect the sensitivity of human ovarian cancer cells to antiprogestin-induced cytotoxicity. Journal of Ovarian Research 7:1.
Crossref
Crossref
Susana Cunha, Lurdes Gano, Goreti Ribeiro Morais, Thies Thiemann & Maria Cristina Oliveira. (2013) Progesterone receptor targeting with radiolabelled steroids: An approach in predicting breast cancer response to therapy. The Journal of Steroid Biochemistry and Molecular Biology 137, pages 223-241.
Crossref
Crossref
Xiao-li Wu, Zhi-hong Yu, Jun Qiu, Yi-hong Yang, Xiao-li Shen & Ping Su. (2013) Postcoital administration of asoprisnil inhibited embryo implantation and disturbed ultrastructure of endometrium in implantation window in mice. Journal of Huazhong University of Science and Technology [Medical Sciences] 33:2, pages 277-283.
Crossref
Crossref
Carlos D Gamarra-Luques, Alicia A Goyeneche, Maria B Hapon & Carlos M Telleria. (2012) Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy. BMC Cancer 12:1.
Crossref
Crossref
Scott J. Lusher, Hans C.A. Raaijmakers, Diep Vu-Pham, Bert Kazemier, Rolien Bosch, Ross McGuire, Rita Azevedo, Hans Hamersma, Koen Dechering, Arthur Oubrie, Marcel van Duin & Jacob de Vlieg. (2012) X-ray Structures of Progesterone Receptor Ligand Binding Domain in Its Agonist State Reveal Differing Mechanisms for Mixed Profiles of 11β-Substituted Steroids. Journal of Biological Chemistry 287:24, pages 20333-20343.
Crossref
Crossref
Ángeles Morales Martínez. (2012) Actualización en anticoncepción de emergencia. FMC - Formación Médica Continuada en Atención Primaria 19:6, pages 353-364.
Crossref
Crossref
Alicia A. Goyeneche, Erin E. Seidel & Carlos M. Telleria. (2011) Growth inhibition induced by antiprogestins RU-38486, ORG-31710, and CDB-2914 in ovarian cancer cells involves inhibition of cyclin dependent kinase 2. Investigational New Drugs 30:3, pages 967-980.
Crossref
Crossref
Chunyu Wang & Powel H. Brown. 2012. Genetically Engineered Mice for Cancer Research. Genetically Engineered Mice for Cancer Research
497
526
.
Chelsea R Tieszen, Alicia A Goyeneche, BreeAnn N Brandhagen, Casey T Ortbahn & Carlos M Telleria. (2011) Antiprogestin mifepristone inhibits the growth of cancer cells of reproductive and non-reproductive origin regardless of progesterone receptor expression. BMC Cancer 11:1.
Crossref
Crossref
Scott J. Lusher, Hans C.A. Raaijmakers, Diep Vu-Pham, Koen Dechering, Tsang Wai Lam, Angus R. Brown, Niall M. Hamilton, Olaf Nimz, Rolien Bosch, Ross McGuire, Arthur Oubrie & Jacob de Vlieg. (2011) Structural Basis for Agonism and Antagonism for a Set of Chemically Related Progesterone Receptor Modulators. Journal of Biological Chemistry 286:40, pages 35079-35086.
Crossref
Crossref
Ethan H. Beckley, Angela C. Scibelli & Deborah A. Finn. (2011) Progesterone receptor antagonist CDB-4124 increases depression-like behavior in mice without affecting locomotor ability. Psychoneuroendocrinology 36:6, pages 824-833.
Crossref
Crossref